| Cognitive function in breast cancer patients receiving adjuvant chemotherapy CB Brezden, KA Phillips, M Abdolell, T Bunston, IF Tannock Journal of Clinical Oncology 18 (14), 2695-2701, 2000 | 723 | 2000 |
| Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 … SM Swain, D Miles, SB Kim, YH Im, SA Im, V Semiglazov, E Ciruelos, ... The Lancet Oncology 21 (4), 519-530, 2020 | 591 | 2020 |
| Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C … AR Lyon, S Dent, S Stanway, H Earl, C Brezden‐Masley, A Cohen‐Solal, ... European journal of heart failure 22 (11), 1945-1960, 2020 | 497 | 2020 |
| Association of pathologic complete response to neoadjuvant therapy in HER2-positive breast cancer with long-term outcomes: a meta-analysis KR Broglio, M Quintana, M Foster, M Olinger, A McGlothlin, SM Berry, ... JAMA oncology 2 (6), 751-760, 2016 | 310 | 2016 |
| Canadian Cardiovascular Society guidelines for evaluation and management of cardiovascular complications of cancer therapy SA Virani, S Dent, C Brezden-Masley, B Clarke, MK Davis, DS Jassal, ... Canadian Journal of Cardiology 32 (7), 831-841, 2016 | 272 | 2016 |
| Use of an abridged scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpatient setting DK Gabrielson, D Scaffidi, E Leung, L Stoyanoff, J Robinson, ... Nutrition and cancer 65 (2), 234-239, 2013 | 228 | 2013 |
| Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised … CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ... The Lancet Oncology 20 (3), 420-435, 2019 | 226 | 2019 |
| Outlooks on Epstein-Barr virus associated gastric cancer M Naseem, A Barzi, C Brezden-Masley, A Puccini, MD Berger, ... Cancer treatment reviews 66, 15-22, 2018 | 196 | 2018 |
| Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines SA Acuna, JW Huang, AL Scott, S Micic, C Daly, C Brezden-Masley, ... American Journal of Transplantation 17 (1), 103-114, 2017 | 180 | 2017 |
| BRCA1 is an essential regulator of heart function and survival following myocardial infarction PC Shukla, KK Singh, A Quan, M Al-Omran, H Teoh, F Lovren, L Cao, ... Nature communications 2 (1), 593, 2011 | 139 | 2011 |
| Overcoming endocrine resistance in hormone receptor–positive breast cancer A AlFakeeh, C Brezden-Masley Current oncology 25 (s1), 18-27, 2018 | 131 | 2018 |
| Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines A Matutino, AA Joy, C Brezden-Masley, S Chia, S Verma Current Oncology 25 (s1), 131-141, 2018 | 88 | 2018 |
| The temporal risk of heart failure associated with adjuvant trastuzumab in breast cancer patients: a population study HA Goldhar, AT Yan, DT Ko, CC Earle, GA Tomlinson, ME Trudeau, ... Journal of the National Cancer Institute 108 (1), djv301, 2016 | 84 | 2016 |
| Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy G Ong, C Brezden-Masley, V Dhir, DP Deva, KKW Chan, CM Chow, ... International Journal of Cardiology 261, 228-233, 2018 | 78 | 2018 |
| Mammographic microcalcifications and breast cancer tumorigenesis: a radiologic-pathologic analysis M Naseem, J Murray, JF Hilton, J Karamchandani, D Muradali, ... BMC cancer 15, 1-9, 2015 | 67 | 2015 |
| Serial cardiovascular magnetic resonance strain measurements to identify cardiotoxicity in breast cancer: comparison with echocardiography CP Houbois, M Nolan, E Somerset, T Shalmon, M Esmaeilzadeh, ... Cardiovascular Imaging 14 (5), 962, 2021 | 66 | 2021 |
| BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis KK Singh, PC Shukla, A Quan, M Al-Omran, F Lovren, Y Pan, ... The Journal of Thoracic and Cardiovascular Surgery 146 (4), 949-960. e4, 2013 | 62 | 2013 |
| Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting MK Krzyzanowska, M Pintilie, C Brezden-Masley, R Dent, IF Tannock Journal of clinical oncology 22 (10), 1993-1999, 2004 | 61 | 2004 |
| Clinicians’ perspectives on barriers to discussing infertility and fertility preservation with young women with cancer A Covelli, M Facey, E Kennedy, C Brezden-Masley, AA Gupta, ... JAMA network open 2 (11), e1914511-e1914511, 2019 | 57 | 2019 |
| Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective … A Barthur, C Brezden-Masley, KA Connelly, V Dhir, KKW Chan, R Haq, ... Journal of Cardiovascular Magnetic Resonance 19 (1), 44, 2016 | 57 | 2016 |
